RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 102.3191

Change

+1.54 (+1.53)%

Market Cap

N/A

Volume

899.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+1.03 (+3.39%)

USD 11.35B
QLD ProShares Ultra QQQ

+2.53 (+2.55%)

USD 7.34B
FNGU MicroSectors FANG+ Index 3X Le..

+22.66 (+5.27%)

USD 5.84B
SSO ProShares Ultra S&P500

+2.11 (+2.39%)

USD 5.40B
UPRO ProShares UltraPro S&P500

+3.00 (+3.61%)

USD 4.05B
TECL Direxion Daily Technology Bull..

+3.49 (+4.19%)

USD 3.15B
YINN Direxion Daily FTSE China Bull..

+2.38 (+7.01%)

USD 2.18B
USD ProShares Ultra Semiconductors

+5.90 (+4.62%)

USD 1.31B
LABU Direxion Daily S&P Biotech Bul..

+5.23 (+4.10%)

USD 0.91B
DPST Direxion Daily Regional Banks ..

+5.50 (+5.25%)

USD 0.74B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
ASWA:XETRA European Green Deal UCITS.. 2.35 % 0.00 %

-0.02 (-0.25%)

USD 0.02B
VXM:CA First Asset Morningstar I.. 0.56 % 0.70 %

+0.23 (+-0.25%)

CAD 0.01B
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.40 (+-0.25%)

USD 0.10B
VXM-B:CA CI Morningstar Internatio.. 0.00 % 0.00 %

-0.03 (-0.25%)

CAD 0.29B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+0.63 (+-0.25%)

USD 8.70B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

+1.65 (+-0.25%)

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.19 (+-0.25%)

USD 0.24B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.21 (+-0.25%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -86.01% 17% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -86.01% 17% F 2% F
Trailing 12 Months  
Capital Gain -84.27% 12% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -84.27% 12% F 2% F
Trailing 5 Years  
Capital Gain -76.19% 26% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -76.19% 26% F 6% D-
Average Annual (5 Year Horizon)  
Capital Gain 13.27% 31% F 74% C
Dividend Return 13.50% 30% F 70% C-
Total Return 0.22% 22% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 30.23% 96% N/A 34% F
Risk Adjusted Return 44.64% 76% C+ 62% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.